HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sybilla Matuszczak Selected Research

Sybilla Matuszczak Research Topics

Disease

10Neoplasms (Cancer)
01/2023 - 01/2012
7Melanoma (Melanoma, Malignant)
01/2023 - 01/2012
2Necrosis
08/2021 - 08/2014
1Squamous Cell Carcinoma of Head and Neck
06/2023
1Bites and Stings (Sting)
01/2023
1Breast Neoplasms (Breast Cancer)
01/2023
1Colorectal Neoplasms (Colorectal Cancer)
10/2022
1Neoplasm Metastasis (Metastasis)
01/2021
1Vascular Tissue Neoplasms
06/2020
1Cardiomyopathies (Cardiomyopathy)
04/2019
1Hypoxia (Hypoxemia)
01/2018
1Infarction (Infarctions)
02/2014
1Cicatrix (Scar)
02/2014

Drug/Important Bio-Agent (IBA)

4Interleukin-12 (IL 12)IBA
01/2021 - 08/2014
2CytokinesIBA
06/2023 - 10/2012
2VaccinesIBA
06/2020 - 12/2015
1ChemokinesIBA
06/2023
1fosbretabulin (combretastatin A4)IBA
01/2023
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1InterferonsIBA
01/2023
1Proteins (Proteins, Gene)FDA Link
01/2023
1SeleniumIBA
10/2022
1QuercetinIBA
10/2022
1PolyphenolsIBA
10/2022
1ResveratrolIBA
10/2022
1Vitamin EFDA LinkGeneric
10/2022
1vadimezanIBA
08/2021
1EndoglinIBA
01/2018
1DNA VaccinesIBA
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1PhosphatidylserinesIBA
08/2014
1Peptides (Polypeptides)IBA
08/2014
1D-K6L9 peptideIBA
08/2014
1Glycyrrhizic Acid (Glycyrrhizin)IBA
08/2014
1SolutionsIBA
02/2014
1HMGB1 Protein (HMG1)IBA
10/2012
1vasostatinIBA
01/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2012

Therapy/Procedure

6Therapeutics
01/2023 - 01/2012
4Radiotherapy
06/2023 - 01/2018
2Brachytherapy
08/2021 - 06/2020
1Immunotherapy
01/2023
1Heart Transplantation (Grafting, Heart)
04/2019
1Drug Therapy (Chemotherapy)
01/2018